ClinicalTrials.Veeva

Menu

Promoting Palliative Care for People With Heart Failure (P3HF)

Yale University logo

Yale University

Status

Not yet enrolling

Conditions

Heart Failure
Palliative Care

Treatments

Behavioral: Clinical Decision Support Tool

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT06933875
2000038269
1R34HL174885-01 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

This project will develop and test a novel clinical decision support tool (CDS) that encourages timely referral to palliative care for people hospitalized with heart failure. This intervention will incorporate an existing, validated 1-year mortality risk model into a CDS to deliver prognostic information and evidence-based decision support at the point of care. Thus, this research may lead to improved care-concordant and goal-directed care for people with heart failure.

Full description

Healthcare providers will encounter the tool during the routine care of their hospitalized patients. Providers randomized to the intervention arm will receive training on the use of the tool and complete one post-trial survey. Providers randomized to the intervention arm will also have the opportunity to participate in 1 post-trial interview. Level 2 providers will participate in one interview.

Enrollment

1,485 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Healthcare providers must meet the following criteria:

  • Are an attending physician, fellow, or resident, advanced practice nurse, or physician associate
  • Has ordering privileges
  • Are members of one of the hospitals' admitting teams (e.g., hospitalist service, cardiology service)
  • Anticipate employment at one of the two study sites for the 15-month trial period.

Or

  • Palliative care team member
  • Hospital administrator/quality and safety personnel

Patients of providers enrolled in the study must meet the following criteria for heart failure during hospitalization:

  • N-terminal pro-B-type natriuretic peptide values of >500 pg/ml
  • Not pregnant at the time of admission.
  • Received intravenous diuretics within 24 hours of admission.

Exclusion criteria

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

1,485 participants in 3 patient groups

Clinical Decision Support (CDS) Tool
Experimental group
Description:
Providers will use the CDS tool to deliver prognostic information and evidence-based decision support at the point of care for timely referral to palliative care for participants hospitalized with heart failure.
Treatment:
Behavioral: Clinical Decision Support Tool
Standard of Care
No Intervention group
Description:
Providers will provide usual standard of care for participants hospitalized with heart failure.
Level 2 providers
Experimental group
Description:
Level 2 providers are providers potentially impacted by the tool. Level 2 providers will participate in one interview.
Treatment:
Behavioral: Clinical Decision Support Tool

Trial contacts and locations

2

Loading...

Central trial contact

Nathan Wright, MA; Shelli Feder, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems